SynthesisMedicine2019

A meta-analysis of efficacy and safety of sorafenib versus other targeted agents for metastatic renal cell carcinoma.

Hai-Tao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.